Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomoxetine and Cerebrovascular Outcomes in Adults

NCT00634439 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00634439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00634439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomoxetine and Cerebrovascular Outcomes in Adults
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
September 30, 2008
Enrollment
72,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, cerebrovascular accident, transient ischemic attack